| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/16/2000 | US6063905 Recombinant human IGA-J. chain dimer |
| 05/16/2000 | US6063903 Ligands for EPH-like receptors |
| 05/16/2000 | US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | US6063756 Insecticidal polypeptides |
| 05/16/2000 | US6063755 Polypeptides with amino acid sequennces encoded by cdna clone |
| 05/16/2000 | US6063621 Hybridoma cell qcrl-1 having atcc accession number hb 11765; for production of monoclonal antibodies for use as antitumor agents and diagnostic reagents |
| 05/16/2000 | US6063620 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 05/16/2000 | US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063596 G-protein coupled receptors associated with immune response |
| 05/16/2000 | US6063594 DNA encoding a novel human anion channel |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063575 Assay for measuring the activity and fidelity of DNA replication and kit therefor |
| 05/16/2000 | US6063379 Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies |
| 05/16/2000 | CA2131826C Mn gene and protein |
| 05/11/2000 | WO2000026671A1 Detection of acid-resistant micro-organisms in a stool |
| 05/11/2000 | WO2000026667A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 05/11/2000 | WO2000026418A1 Human pan-hcv human monoclonal antibodies |
| 05/11/2000 | WO2000026407A1 Method for determining cancer by determining expression of mage-10 |
| 05/11/2000 | WO2000026402A1 Method and test kit for analyzing dns repair |
| 05/11/2000 | WO2000026394A1 Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 05/11/2000 | WO2000026383A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026375A2 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
| 05/11/2000 | WO2000026373A1 MURINE EXPRESSION OF HUMAN Igμ LOCUS |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026369A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 05/11/2000 | WO2000026363A1 GENOMIC AND COMPLETE cDNA SEQUENCES OF HUMAN ADIPOCYTE-SPECIFIC APM1 AND BIALLELIC MARKERS THEREOF |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026342A1 Method of interfering with cell proliferation |
| 05/11/2000 | WO2000026256A2 Modified antibodies and antibody fragments with increased duration of activity |
| 05/11/2000 | WO2000026255A1 Anti-petasin antibodies, methods for the production thereof and their use |
| 05/11/2000 | WO2000026254A2 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer |
| 05/11/2000 | WO2000026251A2 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026241A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/11/2000 | WO2000026240A2 Streptococcal alpha2m-binding protein |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026227A1 Ldl related protein and uses thereof |
| 05/11/2000 | WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | WO2000025816A1 Treatment of hepatitis c by administration of anti-il-2 receptor monoclonal antibody and an antiviral compound |
| 05/11/2000 | WO2000025812A2 Method for preparing solid phase conjugate vaccines |
| 05/11/2000 | WO2000025808A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 05/11/2000 | WO2000025807A1 Binding moieties for human parvovirus b19 |
| 05/11/2000 | WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 05/11/2000 | WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS |
| 05/11/2000 | WO2000025696A1 Interactive dental restorative network |
| 05/11/2000 | WO2000025574A1 Production of biomedical peptides and proteins in plants using plant virus vectors |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 05/11/2000 | WO2000008146A3 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
| 05/11/2000 | WO1999066956A9 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP) |
| 05/11/2000 | WO1999054460A3 Human nucleic acid sequences of normal bladder tissue |
| 05/11/2000 | WO1999053036A3 Ste20-related protein kinases |
| 05/11/2000 | WO1999027100A9 Fibroblast growth factor-19 |
| 05/11/2000 | DE19852906A1 Vitamin E bindende Antikörper, Minianitkörper oder Antikörperfragmente und ihre Verwendung Vitamin E binding antibodies, or antibody fragments Minianitkörper and their use |
| 05/11/2000 | CA2353082A1 Modified antibodies and antibody fragments with increased duration of activity |
| 05/11/2000 | CA2349818A1 Membrane transport proteins |
| 05/11/2000 | CA2349759A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 05/11/2000 | CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2349495A1 Nucleic acids and polypeptides specific for pathogenic strains of the neisseria genus |
| 05/11/2000 | CA2349428A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
| 05/11/2000 | CA2349212A1 Myosin heavy chain homolog |
| 05/11/2000 | CA2349158A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348937A1 Method and test kit for analyzing dns repair |
| 05/11/2000 | CA2348756A1 Enhanced vaccines |
| 05/11/2000 | CA2348751A1 Biological materials and methods useful in the diagnosis and treatment of diseases |
| 05/11/2000 | CA2348733A1 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/11/2000 | CA2348421A1 Protein |
| 05/11/2000 | CA2348063A1 Method for preparing solid phase conjugate vaccines |
| 05/11/2000 | CA2347650A1 Transmembrane 4 proteins |
| 05/11/2000 | CA2347119A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 05/11/2000 | CA2329074A1 Production of biomedical peptides and proteins in plants using plant virus vectors |
| 05/11/2000 | CA2317808A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 05/11/2000 | CA2317117A1 Ldl related protein and uses thereof |
| 05/10/2000 | EP0999284A1 Method for screening antimycotic substances using essential genes from c.albicans, and said genes |
| 05/10/2000 | EP0999277A1 Method for expression of recombinant proteins through the use of the effects of stress and stress-response mechanisms in the presence of compatible solutes |
| 05/10/2000 | EP0999270A1 Method of regulating SMN gene expression |
| 05/10/2000 | EP0999269A1 CDNA sequence and genomic organization for a 59.4 kDa neuronal-specific 7 transmembrane protein (pNEU60) |
| 05/10/2000 | EP0999221A1 Antibodies to a mammalian Langerhans cell antigen and their uses |
| 05/10/2000 | EP0998583A1 Method of detecting thrombotic disease risk |
| 05/10/2000 | EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 05/10/2000 | EP0998576A2 Bovine adenovirus type 3 genome |
| 05/10/2000 | EP0998572A2 Aggrecan degrading metallo proteases |
| 05/10/2000 | EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 05/10/2000 | EP0998561A1 Trail receptor |
| 05/10/2000 | EP0998559A1 Mammalian secretory peptide-9 |
| 05/10/2000 | EP0998558A1 Wa545 compositions |
| 05/10/2000 | EP0998556A2 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 05/10/2000 | EP0998555A1 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |